Table 3. Relationship between PDMP levels in patients with KD who had recurrent rising after discontinuation of ASA and who had no rebound of PDMPs level.
| Checking time | PDMPs, nmol | P | |
|---|---|---|---|
| Rebound after discontinuing ASA (n = 17) | No rebound after discontinuing ASA (n = 29) | ||
| At admission | 9.88 ± 3.99 | 13.05 ± 5.57 | 0.047 |
| Immediately after IVIG treatment | 18.07 ± 12.94 | 21.08 ± 13.07 | 0.465 |
| At 9–15 days after IVIG treatment | 7.64 ± 1.87 | 10.30 ± 4.32 | 0.026 |
| At 2 months after the onset of KD | 6.59 ± 1.54 | 7.97 ± 2.36 | 0.043 |
| At 4–5 months after the onset of KD | 11.66 ± 4.19 | 6.05 ± 1.87 | < 0.001 |
PDMP = platelet-derived microparticle, KD = Kawasaki disease, ASA = acetylsalicylic acid, IVIG = intravenous immunoglobulin.